| 1. | Journal Articles | A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk. 
                (Collaboration) 
                1982 | 
          
            | 2. | Journal Articles | Analysis of inhibitory activity of Dilazep (ComelianR) on platelet aggregation 
                (Collaboration) 
                1984 | 
          
            | 3. | Journal Articles | The effect of plasma on platelet function in hypercholesterolemic rabbits and the changes in fatty acid composition of the plasma. 
                (Collaboration) 
                1984 | 
          
            | 4. | Journal Articles | Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. 
                (Collaboration) 
                1990 | 
          
            | 5. | Journal Articles | Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. 
                (Collaboration) 
                1990 | 
          
            | 6. | Journal Articles | Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity. 
                (Collaboration) 
                1990 | 
          
            | 7. | Journal Articles | Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation. 
                (Collaboration) 
                1990 | 
          
            | 8. | Journal Articles | Increased thrombomodulin values in plasma of diabetic men with microangiopathy. 
                (Collaboration) 
                1991 | 
          
            | 9. | Journal Articles | Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced dissminated intravascular coagulation and the effect of heparin. 
                (Collaboration) 
                1992 | 
          
            | 10. | Journal Articles | The potent inhibition of Vapiprost, a novel thromboxane A2 receptor  antagonist, on the secondary aggregation and ATP release of human  platelets. 
                (Collaboration) 
                1997 | 
          
            | 11. | Journal Articles | Characterization of soluble thrombomodulin fragments in human urine. 
                (Collaboration) 
                1998 | 
          
            | 12. | Journal Articles | Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells. 
                (Collaboration) 
                2000 | 
          
            | 13. | Journal Articles | Oxidation products of phospholipid-containing delta-9 fatty acids specifically impair the activity of tissue factor pathway inhibitor. 
                (Collaboration) 
                2002 | 
          
            | 14. | Journal Articles | Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein. 
                (Collaboration) 
                2002 | 
          
            | 15. | Journal Articles | Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. 
                (Collaboration) 
                2004 | 
          
            | 16. | Journal Articles | Drinking water quality from the aspect of element concentrations. 
                (Collaboration) 
                2006 | 
          
  | 5 display | 
  | All display(16) |